Bicycle Therapeutics (BCYC) Interest Coverage Ratio (2021 - 2026)
Bicycle Therapeutics (BCYC) reported Interest Coverage Ratio of 1364.21 for Q1 2026, up 0.9% on a YoY basis from 1352.09 in Q1 2025, and down 214.72% quarter-over-quarter from 433.47 in Q4 2025.
Bicycle Therapeutics (BCYC) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Interest Coverage Ratio for 6 years, with the latest figure at 1364.21 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 0.9% year-over-year to 1364.21; the trailing twelve-month figure through Mar 2026 stood at 1193.81 (down 361.45% YoY), and the FY2025 full-year result was 1199.34, down 888.63% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1364.21, down from 433.47 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 30.92 in Q2 2022, with the low at 1934.73 in Q3 2024.
- Historically, Interest Coverage Ratio has averaged 586.56 across 5 years, with a median of 62.4 in 2023.
- The largest YoY upside for Interest Coverage Ratio was 66.69% in 2025 against a maximum downside of 3463.33% in 2025.
- Bicycle Therapeutics' Interest Coverage Ratio stood at 39.0 in 2022, then plunged by 69.61% to 66.14 in 2023, then tumbled by 1867.35% to 1301.21 in 2024, then surged by 66.69% to 433.47 in 2025, then sank by 214.72% to 1364.21 in 2026.
- The last three Interest Coverage Ratio figures came in at 1364.21 (Q1 2026), 433.47 (Q4 2025), and 1489.8 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | -1,364.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,364.21 |
| Dec 31, 2025 | -433.47 |
| Sep 30, 2025 | -1,489.80 |
| Jun 30, 2025 | -1,603.74 |
| Mar 31, 2025 | -1,376.55 |
| Dec 31, 2024 | -1,301.21 |
| Sep 30, 2024 | -1,934.73 |
| Jun 30, 2024 | -56.61 |
| Mar 31, 2024 | -38.63 |
| Dec 31, 2023 | -66.14 |
| Sep 30, 2023 | -62.40 |
| Jun 30, 2023 | -52.51 |
| Mar 31, 2023 | -51.74 |
| Dec 31, 2022 | -39.00 |
| Sep 30, 2022 | -36.42 |
| Jun 30, 2022 | -30.92 |
| Mar 31, 2022 | -33.48 |
| Dec 31, 2021 | -21.98 |
| Sep 30, 2021 | -17.37 |
| Jun 30, 2021 | -21.10 |